Orthopedic Regenerative Surgical Products Market Size to Exceed $6.87 Billion by 2029 | Growth and Industry Trends
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has the Orthopedic Regenerative Surgical Products Market Grown from 2024 to 2025?
The market size of orthopedic regenerative surgical products has seen robust growth recently. The market value is projected to expand from $4.54 billion in 2024 to $4.91 billion in 2025, boasting a compound annual growth rate (CAGR) of 8.3%. The historical growth can be ascribed to factors like rising aging population, orthopedic injuries, patient requirements, developments in sports medicine, and musculoskeletal disorders.
What Growth Rate Is Anticipated for the Orthopedic Regenerative Surgical Products Market in the Coming Years?
In the forthcoming years, the market size for orthopedic regenerative surgical products is anticipated to undergo robust growth, reaching the mark of $6.87 billion in 2029 with a compound annual growth rate (CAGR) of 8.7%. Factors responsible for this growth in the projection period include regulatory approval, eco-friendly practices, minimally invasive techniques, rehabilitation and physical therapy, as well as joint preservation. During the projection period, the market is likely to be influenced by trends such as enhanced biomaterials, improvements in surgical techniques, the application of artificial intelligence (AI) and predictive analytics, advancements in regenerative medicine, and orthopedic implants.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6764&type=smp
Who Are the Leading Companies in the Orthopedic Regenerative Surgical Products Market?
Major companies operating in the orthopedic regenerative surgical products market include Baxter International Inc., Zimmer Biomet Holdings Inc., Stryker Corporation, Smith&Nephew plc, Allosource, Anika Therapeutics Inc., Vericel Corporation, Amniox Medical Inc., MIMEDX Group Inc., Aptissen S.A, Arthrex Inc., Bioventus LLC, Conmed Corporation, DePuy Synthes Inc., Exactech Inc., Globus Medical Inc., Integra LifeSciences Corporation, Johnson & Johnson Medical Devices group, Kuros Biosciences AG, Medtronic plc, NuVasive Inc., Orthofix Medical Inc., Osiris Therapeutics Inc., RTI Surgical Inc., SeaSpine Holdings Corporation, Terumo BCT Inc., Tissue Regenix Group plc, Wright Medical Group N.V., Xtant Medical Holdings Inc., Camber Spine Technologies, Lima Corporate, Life Spine Inc., CollPlant Biotechnologies Ltd.
What Are the Key Drivers of the Orthopedic Regenerative Surgical Products Market?
The global increase in orthopedic ailments is expected to boost the expansion of the orthopedic regenerative surgical products industry. These products play a significant role in forestalling orthopedic issues such as fractures, sprains, and strains, along with chronic situations connected with ongoing functional limitations and disability. For example, a report released by the Australian Bureau of Statistics in June 2024 indicated that musculoskeletal conditions accounted for 12.8% of the total disease burden (DALY), 23.1% of non-fatal burden (YLD), and 0.8% of fatal burden (YLL) in 2023. In 2022, these conditions were the root and/or associative cause of 10,446 deaths (40 per 100,000 population), comprising 5.5% of all fatalities. Consequently, the escalating prevalence of orthopedic diseases propels the orthopedic regenerative surgical products market growth.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=6764&type=smp
What Are the Key Market Segments in the Orthopedic Regenerative Surgical Products Industry?
The orthopedic regenerative surgical products market covered in this report is segmented –
1) By Product: Allograft, Synthetic, Cell-based, Viscosupplements
2) By Application: Orthopedic Pain Management, Trauma Repair, Cartilage and Tendon Repair, Joint Reconstruction
3) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Allograft: Bone Allograft, Soft Tissue Allograft, Osteoinductive Allograft, Osteoconductive Allograft
2) By Synthetic: Synthetic Bone Grafts, Synthetic Soft Tissue Grafts, Composite Synthetic Grafts
3) By Cell-based: Stem Cell Therapies, Platelet-Rich Plasma (PRP), Mesenchymal Stem Cells (MSCs)
4) By Viscosupplements: Hyaluronic Acid Injections, Sodium Hyaluronate, Other Viscosupplement Products
What Are the Latest Trends in the Orthopedic Regenerative Surgical Products Market?
The rise of technological innovations has become a significant trend in the orthopedic regenerative surgical products market. In May 2022, for example, the American biopharmaceutical firm, Ocugen Inc., introduced its Phase 3 cell therapy platform technology called NeoCart, created from autologous chondrocyte-derived neocartilage. Recently, the Regenerative Medicine Advanced Therapy (RMAT) designation was granted to NeoCart by the U.S. Food and Drug Administration (FDA) for its role in the repair of full-thickness lesions in adult knee cartilage.
Access The Full Report Here:
What Are the Key Regional Markets in the Orthopedic Regenerative Surgical Products Industry?
North America was the largest region in the orthopedic regenerative surgical products market in 2024 and is also expected to be the fastest-growing region in the forecast period. The regions covered in the orthopedic regenerative surgical products market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6764
This Report Delivers Insight On:
1. How big is the orthopedic regenerative surgical products market, and how is it changing globally?
2. Who are the major companies in the orthopedic regenerative surgical products market, and how are they performing?
3. What are the key opportunities and risks in the orthopedic regenerative surgical products market right now?
4. Which products or customer segments are growing the most in the orthopedic regenerative surgical products market?
5. What factors are helping or slowing down the growth of the orthopedic regenerative surgical products market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
